تيڤاعديرم إسرائيل - العربية - Ministry of Health

تيڤاعديرم

teva pharmaceutical indust.ltd - diflucortolone valerate 0.1 %; isoconazole nitrate 1 % - cream - diflucortolone - for the local treatment of inflammatory skin conditions accompanied by secondary fungal infections.

تيڤعكوتان إسرائيل - العربية - Ministry of Health

تيڤعكوتان

teva pharmaceutical indust.ltd - clotrimazole 1 %; dexamethasone acetate 0.044 % - cream - dexamethasone - tevacutan is indicated for the treatment of mycotic infections of the skin complicated by inflammation and/or secondary infection.

تيرازوسين تيڤع ٥ ملغ إسرائيل - العربية - Ministry of Health

تيرازوسين تيڤع ٥ ملغ

teva pharmaceutical indust.ltd - terazosin as hydrochloride dihydrate 5 mg - tablets - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

بيكالوتاميد تيڤع ١٥٠ ملغ إسرائيل - العربية - Ministry of Health

بيكالوتاميد تيڤع ١٥٠ ملغ

teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

أناستروزول تيڤع إسرائيل - العربية - Ministry of Health

أناستروزول تيڤع

teva pharmaceutical indust.ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

ليتروزول تيڤع إسرائيل - العربية - Ministry of Health

ليتروزول تيڤع

teva pharmaceutical indust.ltd - letrozole 2.5 mg - tablets - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

ايتودولاك ER تيڤع ٤٠٠ ملغ إسرائيل - العربية - Ministry of Health

ايتودولاك er تيڤع ٤٠٠ ملغ

teva pharmaceutical indust.ltd - etodolac 400 mg - tablets - etodolac - for the management of signs and symptoms of osteoarthritis and rehumatoid arthritis.

أليندرونات تيڤع ٧٠ ملغ إسرائيل - العربية - Ministry of Health

أليندرونات تيڤع ٧٠ ملغ

teva pharmaceutical indust.ltd - alendronic acid as sodium 70 mg - tablets - alendronic acid - for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.

كود أكامول ١٥/٣٢٥ إسرائيل - العربية - Ministry of Health

كود أكامول ١٥/٣٢٥

teva pharmaceutical indust.ltd - codeine phosphate 15.0 mg; paracetamol 325 mg - tablets - paracetamol, combinations excl. psycholeptics - relief of mild to moderate pain. relief of fever and cough associated with fever.

توپيرامات تيڤع ١٠٠ ملغ إسرائيل - العربية - Ministry of Health

توپيرامات تيڤع ١٠٠ ملغ

teva pharmaceutical indust.ltd - topiramate 100 mg - tablets - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .